🇺🇸 Short selling in United States, Q3 2021

From 15 Jul 2021 to 30 Sep 2021, 4,483 United States companies carried disclosed short positions. The quarter's highest single reading was Ernexa Therapeutics Inc. at 63.35% on 30 Jul 2021. 442 companies appeared in the data for the first time. 55 left it. Figures are disclosed positions from official FINRA data.

← Q2 2021 Q4 2021 →

Cite this page

Plain

Short position data for Short selling in United States, Q3 2021: FINRA, compiled by howshorted.com, settlement date 30 Sep 2021. https://howshorted.com/us/review/2021-q3/

Wikipedia

<ref>{{cite web |title=Short selling in United States, Q3 2021 short position data |url=https://howshorted.com/us/review/2021-q3/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2021-09-30 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-short-selling-in-united-states-q3-2021-2021-09-30,
  title        = {Short selling in United States, Q3 2021 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/review/2021-q3/}},
  note         = {Data: FINRA, settlement date 30 Sep 2021; accessed 2026-10-13},
  year         = {2021}
}

Biggest rises of the quarter

Sphere 3D Corp. Common Shares+17.29pp to 26.83%
INTERCEPT PHARMACEUTICALS, INC.+11.97pp to 26.88%
FILANA THERAPEUTICS, INC.+10.84pp to 21.92%
MARIN SOFTWARE INC+10.74pp to 15.77%
Sonnet BioTherapeutics Holdings, Inc.+10.54pp to 20.50%

Biggest falls of the quarter

Ernexa Therapeutics Inc.−47.86pp to 1.62%
Creatd Inc.−11.22pp to 5.46%
Antelope Enterprise Holdings Ltd−10.43pp to 6.20%
Evofem Biosciences, Inc.−9.43pp to 17.87%
Tilray Brands, Inc.−9.25pp to 8.51%

Changes compare each company's last figure of the quarter with its first; companies with a single report in the quarter are counted but not ranked. Where disclosure thresholds apply the figures are floors, not a census. Nothing here is investment advice.